Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download

  Prostate Cancer

  Free Subscription


26.10.2020

1 AJR Am J Roentgenol
1 Am J Clin Pathol
1 Am J Surg Pathol
1 BJU Int
2 BMC Urol
2 Br J Radiol
1 Cancer
1 Cancer Res
1 Eur J Radiol
6 Eur Urol
1 Genes Chromosomes Cancer
2 Int J Radiat Oncol Biol Phys
1 Int J Urol
3 J Magn Reson Imaging
13 J Urol
1 Lancet Oncol
2 PLoS One
5 Prostate
1 Urol Int
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. GALGANO SJ, McDonald AM, Rais-Bahrami S, Porter KK, et al
    Utility of (18)F-Fluciclovine PET/MRI for Staging Newly Diagnosed High-Risk Prostate Cancer and Evaluating Response to Initial Androgen Deprivation Therapy: A Prospective Single-Arm Pilot Study.
    AJR Am J Roentgenol. 2020 Oct 14. doi: 10.2214/AJR.20.24509.
    PubMed         Abstract available


    Am J Clin Pathol

  2. SWANSON GP, Trevathan S, Hammonds KAP, Speights VO, et al
    Gleason Score Evolution and the Effect on Prostate Cancer Outcomes.
    Am J Clin Pathol. 2020 Oct 20. pii: 5933242. doi: 10.1093.
    PubMed         Abstract available


    Am J Surg Pathol

  3. VAN LEENDERS GJLH, van der Kwast TH, Grignon DJ, Evans AJ, et al
    The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
    Am J Surg Pathol. 2020;44:e87-e99.
    PubMed         Abstract available


    BJU Int

  4. SCHOOTS IG, Padhani AR
    Risk-adapted biopsy decision based on prostate MRI and PSA-density for enhanced biopsy avoidance in first prostate cancer diagnostic work-up.
    BJU Int. 2020 Oct 21. doi: 10.1111/bju.15277.
    PubMed         Abstract available


    BMC Urol

  5. UEMURA H, Koroki Y, Iwaki Y, Imanaka K, et al
    Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study.
    BMC Urol. 2020;20:166.
    PubMed         Abstract available

  6. LOURENCO DB, Amaral BS, Alfer-Junior W, Vasconcellos A, et al
    Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.
    BMC Urol. 2020;20:163.
    PubMed         Abstract available


    Br J Radiol

  7. UGURLUER G, Atalar B, Zoto Mustafayev T, Gungor G, et al
    Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results.
    Br J Radiol. 2020 Oct 23:20200696. doi: 10.1259/bjr.20200696.
    PubMed         Abstract available

  8. ALONGI F, Rigo M, Figlia V, Cuccia F, et al
    Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
    Br J Radiol. 2020 Oct 23:20200848. doi: 10.1259/bjr.20200848.
    PubMed         Abstract available


    Cancer

  9. RAMIREZ AG, Choi BY, Munoz E, Perez A, et al
    Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32626.
    PubMed         Abstract available


    Cancer Res

  10. MAO N, Gao D, Hu W, Gadal S, et al
    Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
    Cancer Res. 2020;80:1428-1437.
    PubMed         Abstract available


    Eur J Radiol

  11. CHRISTOPHE C, Montagne S, Bourrelier S, Roupret M, et al
    Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
    Eur J Radiol. 2020;132:109350.
    PubMed         Abstract available


    Eur Urol

  12. COOK MB, Hurwitz LM, Geczik AM, Butler EN, et al
    An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.
    Eur Urol. 2020 Oct 19. pii: S0302-2838(20)30768.
    PubMed         Abstract available

  13. CIMADAMORE A, Scarpelli M, Cheng L, Lopez-Beltran A, et al
    Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27-30: Morphologic Documentation from Didact
    Eur Urol. 2020;77:e100-e102.
    PubMed        

  14. SHARMA V, Jeffrey Karnes R
    "To Serve and ProtecT": Has the Pendulum Swung Too Far Towards Surveillance?
    Eur Urol. 2020;77:331-332.
    PubMed        

  15. ZHENGZHENG X, Ge G, Guan B, Lei Z, et al
    Reply to Yejinpeng Wang, Yaoyi Xiong, and Xinghuan Wang's Letter to the Editor re: Zhengzheng Xu, Guangzhe Ge, Bao Guan, et al. Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profi
    Eur Urol. 2020;77:e91-e92.
    PubMed        

  16. WANG Y, Xiong Y, Wang X
    Re: Zhengzheng Xu, Guangzhe Ge, Bao Guan, et al. Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profiles. Eur Urol 2020;77:288-90.
    Eur Urol. 2020;77:e90.
    PubMed        

  17. MONTORSI F, Gandaglia G, Wurnschimmel C, Graefen M, et al
    Re: Paolo Afonso de Carvalho, Joao A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes.
    Eur Urol. 2020 Oct 6. pii: S0302-2838(20)30690.
    PubMed        


    Genes Chromosomes Cancer

  18. NIENTIEDT C, Duensing A, Zschabitz S, Jager D, et al
    PARP inhibition in prostate cancer.
    Genes Chromosomes Cancer. 2020 Oct 21. doi: 10.1002/gcc.22903.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  19. DESAI NB, Garant A, Hannan R, Folkert MR, et al
    Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.
    Int J Radiat Oncol Biol Phys. 2020;108:914-916.
    PubMed        

  20. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    PubMed        


    Int J Urol

  21. NISHIMOTO M, Fujita K, Minami T, Yoshimura K, et al
    Editorial Comment to Relationship between radiation doses and erectile function deterioration in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Int J Urol. 2020 Oct 17. doi: 10.1111/iju.14386.
    PubMed        


    J Magn Reson Imaging

  22. STEPHEN EVANS V, Torrealdea F, Rega M, Brizmohun Appayya M, et al
    Optimization and Repeatability of Multipool Chemical Exchange Saturation Transfer MRI of the Prostate at 3.0 T.
    J Magn Reson Imaging. 2019 Feb 15. doi: 10.1002/jmri.26690.
    PubMed         Abstract available

  23. SUNG K
    Modified MR dispersion imaging in prostate dynamic contrast-enhanced MRI.
    J Magn Reson Imaging. 2019 Feb 17. doi: 10.1002/jmri.26685.
    PubMed         Abstract available

  24. BAO J, Zhi R, Hou Y, Zhang J, et al
    Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
    J Magn Reson Imaging. 2020 Oct 19. doi: 10.1002/jmri.27394.
    PubMed         Abstract available


    J Urol

  25. SAIDIAN A, Fang AM, Hakim O, Magi-Galluzzi C, et al
    Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional Experience.
    J Urol. 2020;204:490-495.
    PubMed         Abstract available

  26. LUITING HB, van Leeuwen PJ, Remmers S, Donswijk M, et al
    Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy.
    J Urol. 2020;204:503-510.
    PubMed         Abstract available

  27. DASKIVICH TJ, Howard LE, Amling CL, Aronson WJ, et al
    Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy.
    J Urol. 2020;204:511-517.
    PubMed         Abstract available

  28. AHMAD AE, Richard PO, Leao R, Hajiha M, et al
    Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?
    J Urol. 2020;204:476-482.
    PubMed         Abstract available

  29. BUISSET J, Norris JM, Puech P, Leroy X, et al
    Negative Pre-biopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Follow-up Results.
    J Urol. 2020 Oct 20:101097JU0000000000001414. doi: 10.1097/JU.0000000000001414.
    PubMed         Abstract available

  30. NAHA U, Nickel JC, Andriole GL, Freedland SJ, et al
    Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study.
    J Urol. 2020 Oct 20:101097JU0000000000001407. doi: 10.1097/JU.0000000000001407.
    PubMed         Abstract available

  31. XU MC, Huelster HL, Hatcher JB, Avulova S, et al
    Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    J Urol. 2020 Oct 20:101097JU0000000000001428. doi: 10.1097/JU.0000000000001428.
    PubMed         Abstract available

  32. HELFAND BT, Glaser AP
    Editorial Comment.
    J Urol. 2020;204:700.
    PubMed        

  33. LOPEZ F, Macpherson R, Lamb A
    Editorial Comment.
    J Urol. 2020;204:670.
    PubMed        

  34. VALERIO M
    Editorial Comment.
    J Urol. 2020;204:747.
    PubMed        

  35. BARBIERI CE
    Editorial Comment.
    J Urol. 2020;204:712-713.
    PubMed        

  36. GINSBURG KB, Curtis GL, Timar RE, George AK, et al
    Reply by Authors.
    J Urol. 2020;204:845.
    PubMed        

  37. MANO R
    Editorial Comment.
    J Urol. 2020;204:713.
    PubMed        


    Lancet Oncol

  38. KNEEBONE A, Fraser-Browne C, Duchesne GM, Fisher R, et al
    Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
    Lancet Oncol. 2020;21:1331-1340.
    PubMed         Abstract available


    PLoS One


  39. Correction: MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.
    PLoS One. 2020;15:e0241462.
    PubMed         Abstract available

  40. KALINAUSKAITE G, Senger C, Kluge A, Furth C, et al
    68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer.
    PLoS One. 2020;15:e0240892.
    PubMed         Abstract available


    Prostate

  41. YANG Y, Attwood K, Bshara W, Mohler JL, et al
    High intratumoral CD8(+) T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy.
    Prostate. 2020 Oct 21. doi: 10.1002/pros.24068.
    PubMed         Abstract available

  42. MIYAHIRA AK, Soule HR
    The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Prostate. 2020 Oct 21. doi: 10.1002/pros.24083.
    PubMed         Abstract available

  43. WASHINGTON SL 3RD, Cowan JE, Herlemann A, Zuniga KB, et al
    Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
    Prostate. 2020 Oct 19. doi: 10.1002/pros.24085.
    PubMed         Abstract available

  44. AMELOT A, Terrier LM, Le Nail LR, Cristini J, et al
    Spine metastasis in patients with prostate cancer: Survival prognosis assessment.
    Prostate. 2020 Oct 16. doi: 10.1002/pros.24084.
    PubMed         Abstract available

  45. JARRARD D, Filon M, Huang W, Havighurst T, et al
    A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.
    Prostate. 2020 Oct 23. doi: 10.1002/pros.24076.
    PubMed         Abstract available


    Urol Int

  46. TAFURI A, Rizzetto R, Amigoni N, Sebben M, et al
    Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
    Urol Int. 2020 Oct 15:1-8. doi: 10.1159/000510008.
    PubMed         Abstract available


    Urology

  47. DE ALMEIDA RVS, Silvino JRC, Kalil JR, Junior VLDS, et al
    Early Effects of High-Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology.
    Urology. 2020 Oct 17. pii: S0090-4295(20)31265.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: